LiverSeek: Finding advanced liver scarring in MASLD
Part of Digestive system, Hormones & metabolism clinical trials.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 75 years old.
- Your blood test was ordered by your primary care doctor at one of 11 participating SERMAS centers in Madrid.
- You have at least one of these: high ALT and high blood sugar, high ALT and a BMI over 30, or a BMI over 30 and high blood sugar.
- You do not already have known serious liver disease (like cirrhosis or liver cancer) or have had a liver scarring test in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new screening tool to find advanced liver scarring in people with liver disease linked to diabetes. It helps doctors decide who needs more tests or specialist care.
This study is testing whether advanced imaging and other non-invasive methods can properly identify people with significant liver scarring due to metabolic liver disease or alcohol-related liver disease. It may help find better ways to track liver health without repeated needle biopsies.
This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.
This study is building a model to better predict how metabolic liver disease (MASLD) that has led to cirrhosis (scarring of the liver) will progress. If you have compensated cirrhosis (your liver is still working well) and have been diagnosed with MASLD or a related condition, this research could help develop more personalized care.
This study looks at factors that predict liver cancer and the need for a liver transplant in people with a liver condition called MASLD (metabolic dysfunction-associated steatotic liver disease). The goal is to better understand the disease and improve care.
This study is checking people with type 2 diabetes for early signs of liver scarring (fibrosis) caused by MASLD, a common fatty liver condition. If you have diabetes and no known advanced liver damage, this screening could help find problems early.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.